ABSTRACT
In Chapter 19, “Designer Benzodiazepines: New Challenges and Treatment Options”, Peter Maskell and Nathan Wilson focus on new designer/NPS benzodiazepines, which have been recently detected and caused a series of fatalities in both the United States and the United Kingdom. This chapter provides an overview on benzodiazepine abuse, including desired and side effects, while drawing parallels with licenced benzodiazepines and how new benzodiazepines have emerged inside that framework of abuse. The chapter also explores the cases of acute hospital admission and provides advice for the clinical management in case of overdose and intoxication.
